Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 14/20 | 0.46 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2437881 | 0.89 | MCL1 (0.47) | P2RX3MCL1UCHL1 | |
| SCHEMBL6208008 | 0.89 | MCL1 (0.47) | P2RX3MCL1UCHL1 | |
| SCHEMBL18103660 | 0.88 | P2RX3 (0.51) | P2RX3MCL1UCHL1NR1H2NR1H3 | |
| SCHEMBL27112502 | 0.88 | P2RX3 (0.51) | P2RX3MCL1UCHL1NR1H2NR1H3 | |
| SCHEMBL948762 | 0.88 | P2RX3 (0.51) | P2RX3MCL1UCHL1NR1H2NR1H3 | |
| SCHEMBL948760 | 0.88 | P2RX3 (0.51) | P2RX3MCL1UCHL1NR1H2NR1H3 | |
| SCHEMBL15719188 | 0.88 | P2RX3 (0.51) | P2RX3MCL1UCHL1NR1H2NR1H3 | |
| SCHEMBL2439746 | 0.88 | P2RX3 (0.51) | P2RX3MCL1UCHL1NR1H2NR1H3 | |
| SCHEMBL24740458 | 0.86 | P2RX3 (0.51) | P2RX3MCL1NR1H2NR1H3PTPN1 | |
| SCHEMBL3862645 | 0.86 | P2RX3 (0.47) | P2RX3MCL1UCHL1NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1346982-B1 | VLA-4 INHIBITORS | DAIICHI SEIYAKU CO (JP) | 2011-09-14 | — | — | EP | disclosed |
| US-7157487-B2 | Vla-4 inhibitors | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |